Showing 21 - 40 results of 22,731 for search '"B.S."', query time: 0.10s Refine Results
  1. 21
  2. 22

    The role of new hepatitis B vaccines in South Africa by G U van Zyl, T Maponga, H Rabie, J Taljaard

    Published 2024-02-01
    Subjects: “…Hepatitis B virus…”
    Get full text
    Article
  3. 23
  4. 24
  5. 25
  6. 26

    New strategies for probing $$B\rightarrow D^*\ell \bar{\nu }_\ell $$ B → D ∗ ℓ ν ¯ ℓ lattice and experimental data by M. Bordone, A. Jüttner

    Published 2025-02-01
    “…Abstract We present an analysis of the exclusive semileptonic decay $$B\rightarrow D^*\ell \bar{\nu }_\ell $$ B → D ∗ ℓ ν ¯ ℓ based on the Belle and Belle II data made public in 2023, combined with recent lattice-QCD calculations of the hadronic transition form factors by FNAL/MILC, HPQCD and JLQCD. …”
    Get full text
    Article
  7. 27
  8. 28
  9. 29
  10. 30

    Knowledge of Healthcare Professionals Regarding Hepatitis B in Rania Hospitals by Zhino Raouf Ali, Mohammed Rasol Ahmed, Khalid Muhamad Hamad, Zhiar Hussen Wsu

    Published 2020-12-01
    Subjects: “…Knowledge, Hepatitis B virus, health care professionals, Rania hospitals, Kurdistan region of Iraq…”
    Get full text
    Article
  11. 31
  12. 32
  13. 33
  14. 34
  15. 35
  16. 36
  17. 37
  18. 38

    Protracted HBsAg-aemia in a Patient with Acute Hepatitis B by K. R. Dudina, O. O. Znoyko

    Published 2018-11-01
    Subjects: “…acute hepatitis b…”
    Get full text
    Article
  19. 39

    Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B by I. G. Bakulin

    Published 2009-02-01
    “…To estimate safety and efficacy of prescription of nucleoside analogues the patient with liver cirrhosis in an outcome of chronic hepatitis B.Original positions of the report. Rates of progression of persistent HBV infection to liver cirrhosis stage depend on several factors – spectrum of viral markers, immune status of the patient, his/her age, gender, genetic predisposition, etc. …”
    Get full text
    Article
  20. 40